Anh T. Le

6.1k total citations · 3 hit papers
56 papers, 3.5k citations indexed

About

Anh T. Le is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Anh T. Le has authored 56 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Pulmonary and Respiratory Medicine, 34 papers in Oncology and 24 papers in Molecular Biology. Recurrent topics in Anh T. Le's work include Lung Cancer Treatments and Mutations (39 papers), Lung Cancer Research Studies (14 papers) and Cancer Genomics and Diagnostics (12 papers). Anh T. Le is often cited by papers focused on Lung Cancer Treatments and Mutations (39 papers), Lung Cancer Research Studies (14 papers) and Cancer Genomics and Diagnostics (12 papers). Anh T. Le collaborates with scholars based in United States, China and Vietnam. Anh T. Le's co-authors include Robert C. Doebele, Dara L. Aisner, Marileila Varella‐Garcia, D. Ross Camidge, Lynn E. Heasley, Andrew Weickhardt, Amanda Pilling, Tatiana G. Kutateladze, Wilbur A. Franklin and Derek J. Linderman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Anh T. Le

56 papers receiving 3.4k citations

Hit Papers

Mechanisms of Resistance to Crizotinib in Patients with A... 2012 2026 2016 2021 2012 2015 2015 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Mechanisms of Resistance to Crizotinib in Patients with ALK Gene Rearranged Non–Small Cell Lung Cancer
    2012 820 citations Robert C. Doebele, Amanda Pilling et al. Clinical Cancer Research profile →
  2. Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): a randomised, double-blind, placebo-controlled, phase 3 trial
    2015 553 citations Anh T. Le et al. profile →
  3. An Oncogenic NTRK Fusion in a Patient with Soft-Tissue Sarcoma with Response to the Tropomyosin-Related Kinase Inhibitor LOXO-101
    2015 302 citations Robert C. Doebele, Lara E. Davis et al. Cancer Discovery profile →

Peers

Anh T. Le
Anthony M. D’Amelio United States
V.A. Miller United States
Giovanna Finocchiaro Italy
Joo Hang Kim South Korea
Vincent Haddad United Kingdom
Sara De Dosso Switzerland
Jin‐Ji Yang China
Alessio Amatu Italy
Jordi Remón France
Susana Roselló Spain
Anthony M. D’Amelio United States
Anh T. Le
Citations per year, relative to Anh T. Le Anh T. Le (= 1×) peers Anthony M. D’Amelio

Countries citing papers authored by Anh T. Le

Since Specialization
Citations

This map shows the geographic impact of Anh T. Le's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anh T. Le with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anh T. Le more than expected).

Fields of papers citing papers by Anh T. Le

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anh T. Le. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anh T. Le. The network helps show where Anh T. Le may publish in the future.

Co-authorship network of co-authors of Anh T. Le

This figure shows the co-authorship network connecting the top 25 collaborators of Anh T. Le. A scholar is included among the top collaborators of Anh T. Le based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anh T. Le. Anh T. Le is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Le, Anh T., et al.. (2023). Intrinsic resistance to ROS1 inhibition in a patient with CD74‐ROS1 mediated by AXL overexpression. Thoracic Cancer. 14(33). 3259–3265. 2 indexed citations
2.
Lai, Wei‐Yun, Ganesh Umapathy, Bengt Bergman, et al.. (2023). ALK fusion NSCLC oncogenes promote survival and inhibit NK cell responses via SERPINB4 expression. Proceedings of the National Academy of Sciences. 120(8). e2216479120–e2216479120. 15 indexed citations
3.
Le, Anh T., Eric A. Welsh, Bin Fang, et al.. (2023). MIG6 Mediates Adaptive and Acquired Resistance to ALK/ROS1 Fusion Kinase Inhibition through EGFR Bypass Signaling. Molecular Cancer Therapeutics. 23(1). 92–105. 3 indexed citations
4.
Lai, Wei‐Yun, Anh T. Le, Susanne Fransson, et al.. (2022). Novel human-derived EML4-ALK fusion cell lines identify ribonucleotide reductase RRM2 as a target of activated ALK in NSCLC. Lung Cancer. 171. 103–114. 7 indexed citations
5.
Wu, Y. Jeffrey, Chetna Sharon, Howard Li, et al.. (2021). High dose acetaminophen inhibits STAT3 and has free radical independent anti-cancer stem cell activity. Neoplasia. 23(3). 348–359. 13 indexed citations
6.
Li, Li, Chunqing Lin, Nan Feng, et al.. (2020). Stigma Related to HIV and Drug Use: Layers, Types, and Relations to Mental Health. AIDS and Behavior. 24(8). 2347–2354. 16 indexed citations
7.
Nguyen, Son Truong, et al.. (2020). Smoking habit and chemo-radiotherapy and/or surgery affect the sensitivity of EGFR plasma test in non-small cell lung cancer. BMC Research Notes. 13(1). 367–367. 1 indexed citations
8.
McCoach, Caroline E., Anh T. Le, Katherine Gowan, et al.. (2018). Resistance Mechanisms to Targeted Therapies in ROS1 + and ALK + Non–small Cell Lung Cancer. Clinical Cancer Research. 24(14). 3334–3347. 179 indexed citations
9.
McCoach, Caroline E., Collin M. Blakely, Kimberly C. Banks, et al.. (2018). Clinical Utility of Cell-Free DNA for the Detection of ALK Fusions and Genomic Mechanisms of ALK Inhibitor Resistance in Non–Small Cell Lung Cancer. Clinical Cancer Research. 24(12). 2758–2770. 114 indexed citations
10.
Neel, Dana S., Victor Olivas, Manasi K. Mayekar, et al.. (2018). Differential Subcellular Localization Regulates Oncogenic Signaling by ROS1 Kinase Fusion Proteins. Cancer Research. 79(3). 546–556. 63 indexed citations
11.
Patil, Tejas, Derek Smith, Paul A. Bunn, et al.. (2018). The Incidence of Brain Metastases in Stage IV ROS1-Rearranged Non–Small Cell Lung Cancer and Rate of Central Nervous System Progression on Crizotinib. Journal of Thoracic Oncology. 13(11). 1717–1726. 138 indexed citations
12.
Le, Anh T., Minjae Yoo, Laura Schubert, et al.. (2017). Resistance to RET-Inhibition in RET-Rearranged NSCLC Is Mediated By Reactivation of RAS/MAPK Signaling. Molecular Cancer Therapeutics. 16(8). 1623–1633. 63 indexed citations
13.
Vaishnavi, Aria, Laura Schubert, Uwe Rix, et al.. (2017). EGFR Mediates Responses to Small-Molecule Drugs Targeting Oncogenic Fusion Kinases. Cancer Research. 77(13). 3551–3563. 61 indexed citations
14.
Dziadziuszko, Rafał, Anh T. Le, Anna Wrona, et al.. (2016). An Activating KIT Mutation Induces Crizotinib Resistance in ROS1-Positive Lung Cancer. Journal of Thoracic Oncology. 11(8). 1273–1281. 63 indexed citations
15.
Doebele, Robert C., Lara E. Davis, Aria Vaishnavi, et al.. (2015). An Oncogenic NTRK Fusion in a Patient with Soft-Tissue Sarcoma with Response to the Tropomyosin-Related Kinase Inhibitor LOXO-101. Cancer Discovery. 5(10). 1049–1057. 302 indexed citations breakdown →
16.
Doebele, Robert C., Amanda Pilling, Dara L. Aisner, et al.. (2012). Mechanisms of Resistance to Crizotinib in Patients with ALK Gene Rearranged Non–Small Cell Lung Cancer. Clinical Cancer Research. 18(5). 1472–1482. 820 indexed citations breakdown →
17.
Davies, Kurtis D., Anh T. Le, Mariana F. Theodoro, et al.. (2012). Identifying and Targeting ROS1 Gene Fusions in Non–Small Cell Lung Cancer. Clinical Cancer Research. 18(17). 4570–4579. 330 indexed citations
18.
Irons, Richard D. & Anh T. Le. (2007). Dithiocarbamates and viral IL-10 collaborate in the immortalization and evasion of immune response in EBV-infected human B lymphocytes. Chemico-Biological Interactions. 172(1). 81–92. 8 indexed citations
19.
Irons, Richard D., Ling Lv, Sherilyn A. Gross, et al.. (2005). Chronic exposure to benzene results in a unique form of dysplasia. Leukemia Research. 29(12). 1371–1380. 32 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anthony M. D’Amelio Breakdown of academic impact, for papers by V.A. Miller Breakdown of academic impact, for papers by Giovanna Finocchiaro Breakdown of academic impact, for papers by Joo Hang Kim Breakdown of academic impact, for papers by Vincent Haddad Breakdown of academic impact, for papers by Sara De Dosso Breakdown of academic impact, for papers by Jin‐Ji Yang Breakdown of academic impact, for papers by Alessio Amatu Breakdown of academic impact, for papers by Jordi Remón Breakdown of academic impact, for papers by Susana Roselló
Rankless by CCL
2026